Category: News

iVis won EP’470 patent validity case against Schwind at the Board of Appeal of EPO
Post

iVis won EP’470 patent validity case against Schwind at the Board of Appeal of EPO

iVIS Technologies was granted the European patent EP 1 428 470 which relates to customized lamellar transplantations of corneal tissue for one of its early innovations. Such transplantations may be used to restore the vision of patients who suffer from corneal diseases such as keratokonus. A customized layer of the patient’s diseased cornea tailored according to patient’s needs is removed and replaced by a healthy layer of a donor cornea.

29 October 20198 November 2019by In News
Impressions of the ESCRS 2019
Post

Impressions of the ESCRS 2019

"Reserve a no-touch, one-step precise surgery for your eyes" – that was the iVIS motto for the ESCRS 2019 and hundreds of visitors followed this invitation.

19 September 20192 October 2019by In News
iVis Technologies participated at XVIII S.I.C.S.S.O. Congress 2019, hosting live surgery & advanced educational sessions
Post

iVis Technologies participated at XVIII S.I.C.S.S.O. Congress 2019, hosting live surgery & advanced educational sessions

This year’s S.I.C.S.S.O took place in Torino from 27th to 29th of June and it was a great success for both iVis Technologies and the greater ophthalmological community. As we continue to innovate and fine-tune our mission to better serve the interests of cornea-refractive surgeons through high-quality education, iVis was eager to present excellent scientific...

iVis Technologies was represented in the eye-catching Italian Trade Agency Pavilion in collaboration with Extraordinary Italian Tech.
Post

iVis Technologies was represented in the eye-catching Italian Trade Agency Pavilion in collaboration with Extraordinary Italian Tech.

The BIO 2019 International Convention in Philadelphia, PA, USA, took place from the 3rd until the 6th of June 2019 as it continues to be the largest biotechnology conference in the world, and this year’s event had a significant international presence. BIO provides an environment where innovative thrives. Once we arrived in Philadelphia, we joined...

  • 1
  • 2